Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Vireo is stocked at 32 licensed dispensaries across New York, Minnesota, and Maryland, 23 of them in New York, with the deepest coverage in New York, Buffalo, Cheektowaga, East Syracuse, and Huntington Station. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Vireo’s category mix in October 2026 was dominated by Concentrates at 90.44% share with 342.02% year-over-year growth and a 6.01% month-over-month lift, while Topical held 5.62% share with a -32.27% year-over-year decline but a 21.22% month-over-month increase; Vapor Pens accounted for 3.05% share with no measurable year-over-year or month-over-month trend. The brand’s average price rose 53.89% year over year to $41.72 as Concentrates priced at $44.61 led mix, and Topical at $22.19 compressed the low end, implying that October 2026 volume expansion rode a higher-priced, extraction-led portfolio that offsets softness in legacy Topical buyers.
These shifts push Vireo toward a concentrate-forward positioning in New York, where rank 24 in Concentrates aligns with a portfolio that concentrates 90.44% of sales in a single category and posts 6.01% month-over-month growth while Topical rebounds 21.22% month over month from a -32.27% year-over-year base. With brand sales up 101.43% year over year but down 72.75% over 24 months, the tilt toward higher-priced Concentrates and a small, volatile Topical base implies near-term share capture via premiumized extracts while longer-horizon stability will require either sustaining triple-digit Concentrates growth or diversifying the 3.05% Vapor Pens share into a second growth pillar.
Competitive Landscape
Vireo is ranked #24 in NY Concentrates in October 2026, improving 14 positions year over year from #38, but sliding 5 spots since July 2026 from #19 as it comes off a peak of #16 in June 2026; this contrasts with UMAMII climbing from #17 to #2 alongside an 813.4% YoY sales increase and RYTHM edging up from #4 to #3 with 71.1% YoY growth, while Jetpacks slipped from #2 to #4 with a -22.9% YoY change. With Mfny (Marijuana Farms New York) holding #1 year over year and in October 2026, the combination of Vireo’s 14-rank YoY climb and a recent 5-rank quarter-over-quarter decline implies momentum that is improving structurally but vulnerable to faster-accelerating competitors, signaling a need to defend mid-pack gains before the category’s top-tier consolidation widens the gap.
Notable Products
Vireo’s October 2026 sales are concentrated in RSO syringes, with the Sativa RSO Syringe (1g) at 38.4% and RSOs overall accounting for 90.4% of brand sales, while there were 0 new products contributing 0.0%. This lineup means most of its sales ride on one format.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






